BG51042A3 - Метод за получаване на безводна,кристална натриева сол на 5-хлор- 3(2-теноил)-2-оксиндол-1-карбоксамид - Google Patents

Метод за получаване на безводна,кристална натриева сол на 5-хлор- 3(2-теноил)-2-оксиндол-1-карбоксамид Download PDF

Info

Publication number
BG51042A3
BG51042A3 BG082816A BG8281688A BG51042A3 BG 51042 A3 BG51042 A3 BG 51042A3 BG 082816 A BG082816 A BG 082816A BG 8281688 A BG8281688 A BG 8281688A BG 51042 A3 BG51042 A3 BG 51042A3
Authority
BG
Bulgaria
Prior art keywords
thenoyl
chloro
sodium salt
carboxamyde
axindole
Prior art date
Application number
BG082816A
Other languages
English (en)
Inventor
Douglas Allen
Brian O'neill
Original Assignee
Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware filed Critical Pfizer Inc., a corporation organized аnd existing under the laws of the State of Delaware
Publication of BG51042A3 publication Critical patent/BG51042A3/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Съединенията намират приложение във фармацевтичната промишленост като аналгетични и противовъзпалителни агенти. По метода хидратна форма на натриевата сол на 5-хлор-3-(2-теноил)-2-оксиндол-1-карбоксамида се смесва с ацетонитрил при стайна температура. 1 претенция
BG082816A 1987-02-02 1988-02-01 Метод за получаване на безводна,кристална натриева сол на 5-хлор- 3(2-теноил)-2-оксиндол-1-карбоксамид BG51042A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/000201 WO1988005656A1 (en) 1987-02-02 1987-02-02 Anhydrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide

Publications (1)

Publication Number Publication Date
BG51042A3 true BG51042A3 (bg) 1993-01-15

Family

ID=22202263

Family Applications (1)

Application Number Title Priority Date Filing Date
BG082816A BG51042A3 (bg) 1987-02-02 1988-02-01 Метод за получаване на безводна,кристална натриева сол на 5-хлор- 3(2-теноил)-2-оксиндол-1-карбоксамид

Country Status (42)

Country Link
US (1) US5036099A (bg)
EP (1) EP0277738B1 (bg)
JP (1) JPS63201184A (bg)
KR (1) KR900001422B1 (bg)
CN (1) CN1022324C (bg)
AP (1) AP52A (bg)
AR (1) AR243182A1 (bg)
AT (1) ATE73800T1 (bg)
AU (1) AU587736B2 (bg)
BG (1) BG51042A3 (bg)
CA (1) CA1335590C (bg)
CS (2) CS265250B2 (bg)
CY (1) CY1775A (bg)
DD (1) DD267490A5 (bg)
DE (1) DE3869149D1 (bg)
DK (1) DK44888A (bg)
EC (1) ECSP941082A (bg)
ES (1) ES2032955T3 (bg)
FI (1) FI89598C (bg)
GR (1) GR3004200T3 (bg)
HK (1) HK132695A (bg)
IE (1) IE60000B1 (bg)
IL (1) IL85277A (bg)
IN (1) IN171799B (bg)
IS (1) IS1533B (bg)
LV (1) LV10252B (bg)
MA (1) MA21171A1 (bg)
MY (1) MY102737A (bg)
NO (1) NO170581C (bg)
NZ (1) NZ223373A (bg)
OA (1) OA08710A (bg)
PH (1) PH26545A (bg)
PL (1) PL149550B1 (bg)
PT (1) PT86675B (bg)
RO (1) RO105052B1 (bg)
RU (1) RU2011381C1 (bg)
SG (1) SG27994G (bg)
SI (1) SI8810183A8 (bg)
UA (1) UA25898A1 (bg)
WO (1) WO1988005656A1 (bg)
YU (1) YU46766B (bg)
ZA (1) ZA88679B (bg)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4853409A (en) * 1988-04-13 1989-08-01 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides for suppressing T-cell function
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
WO1990004393A1 (en) * 1988-10-18 1990-05-03 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
EP0365194B1 (en) * 1988-10-18 1995-08-02 Pfizer Inc. Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides
US5059693A (en) * 1989-10-06 1991-10-22 Pfizer Inc. Process for making 3-aroyl-2-oxindole-1-carboxamides
US5006547A (en) * 1990-03-19 1991-04-09 Pfizer Inc. Tenidap as an inhibitor of the release of elastase by neutrophils
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
US5122534A (en) * 1991-02-08 1992-06-16 Pfizer Inc. Use of tenidap to reduce total serum cholesterol, ldl cholesterol and triglycerides
DE4111305C2 (de) * 1991-04-08 1994-12-01 Mack Chem Pharm Pharmazeutische Zubereitung zur rektalen Applikation, die ein 2-Oxindol-l-carboxamid-derivat enthält
AU7503496A (en) * 1995-12-19 1997-07-14 Pfizer Inc. Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) * 1996-08-21 1998-03-04 Pfizer Inc. Stable, long acting salts of carboxamides for the treatment of joint disease
DE19854355A1 (de) * 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
US7407195B2 (en) 2004-04-14 2008-08-05 William Berson Label for receiving indicia having variable spectral emissivity values
US7651031B2 (en) * 2004-10-25 2010-01-26 William Berson Systems and methods for reading indicium
US7931413B2 (en) * 2005-01-14 2011-04-26 William Berson Printing system ribbon including print transferable circuitry and elements
US7621451B2 (en) * 2005-01-14 2009-11-24 William Berson Radio frequency identification labels and systems and methods for making the same
US7728726B2 (en) * 2005-01-14 2010-06-01 William Berson Radio frequency identification labels
US7619520B2 (en) * 2005-01-14 2009-11-17 William Berson Radio frequency identification labels and systems and methods for making the same
WO2019087191A1 (en) 2017-11-02 2019-05-09 Accurate Medical Therapeutics Ltd. Embolization catheter with integral filter

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
GB1532413A (en) * 1974-12-23 1978-11-15 Union International Co Ltd Chenodeoxycholic acid
DE2613346C3 (de) * 1976-03-29 1981-07-23 Diamalt AG, 8000 München Monoklin kristalline Chenodesoxycholsäure und Verfahren zu ihrer Herstellung
DE3568776D1 (en) * 1984-02-07 1989-04-20 Pfizer 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
DE3579716D1 (de) * 1984-03-19 1990-10-25 Pfizer Verfahren zur herstellung von 2-oxindole-1-carboxamiden und deren zwischenprodukte.
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
YU18388A (en) 1989-10-31
RU2011381C1 (ru) 1994-04-30
IE60000B1 (en) 1994-05-18
SI8810183A8 (sl) 1996-08-31
CA1335590C (en) 1995-05-16
DE3869149D1 (de) 1992-04-23
ATE73800T1 (de) 1992-04-15
UA25898A1 (uk) 1999-02-26
IN171799B (bg) 1993-01-09
PT86675A (pt) 1988-03-01
MA21171A1 (fr) 1988-10-01
MY102737A (en) 1992-09-30
CS64888A2 (en) 1988-08-16
NO884329D0 (no) 1988-09-29
PH26545A (en) 1992-08-19
CN1022324C (zh) 1993-10-06
PL149550B1 (en) 1990-02-28
JPS63201184A (ja) 1988-08-19
LV10252B (en) 1995-04-20
FI893647A0 (fi) 1989-08-01
DK44888D0 (da) 1988-01-29
FI89598C (fi) 1993-10-25
PL270415A1 (en) 1988-12-08
CS354191A3 (en) 1992-04-15
PT86675B (pt) 1992-07-31
CS265250B2 (en) 1989-10-13
NO884329L (no) 1988-09-29
RO105052B1 (en) 1994-12-01
EP0277738A1 (en) 1988-08-10
IS3309A7 (is) 1988-08-03
KR880009961A (ko) 1988-10-06
SG27994G (en) 1994-10-14
AU587736B2 (en) 1989-08-24
LV10252A (lv) 1994-10-20
DD267490A5 (de) 1989-05-03
IE880269L (en) 1988-08-02
US5036099A (en) 1991-07-30
YU46766B (sh) 1994-05-10
NO170581B (no) 1992-07-27
NZ223373A (en) 1989-06-28
AU1116088A (en) 1988-08-04
KR900001422B1 (ko) 1990-03-09
OA08710A (fr) 1989-03-31
ES2032955T3 (es) 1996-07-16
DK44888A (da) 1988-08-03
WO1988005656A1 (en) 1988-08-11
EP0277738B1 (en) 1992-03-18
CY1775A (en) 1996-04-05
FI89598B (fi) 1993-07-15
AP8800081A0 (en) 1987-11-01
CN88100555A (zh) 1988-08-17
NO170581C (no) 1992-11-04
AR243182A1 (es) 1993-07-30
ZA88679B (en) 1989-09-27
IL85277A (en) 1994-02-27
ECSP941082A (es) 1994-12-15
HK132695A (en) 1995-09-01
GR3004200T3 (bg) 1993-03-31
IL85277A0 (en) 1988-07-31
AP52A (en) 1989-09-16
JPH0576945B2 (bg) 1993-10-25
IS1533B (is) 1994-01-28

Similar Documents

Publication Publication Date Title
BG51042A3 (bg) Метод за получаване на безводна,кристална натриева сол на 5-хлор- 3(2-теноил)-2-оксиндол-1-карбоксамид
FI90976C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten indolijohdannaisten ja niiden happoadditiosuolojen valmistamiseksi
PT87754A (pt) Process for the preparation of new amino acid derivatives
LU90677I2 (fr) Esomeprazole et ses sels et d-riv-s pharmaceutiquement acceptables (nexiam)
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
SE9002500D0 (sv) Farmaceutisk, nac-innehaallande komposition foer oral administrering
SE7707462L (sv) Forfarande for framstellning av penicillansyraderivat
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
DE3483798D1 (de) Dihydrodibenzocycloheptylidenethylamin-derivate.
AR248407A1 (es) Un procedimiento para la preparacion de la forma monohidratada cristalina de una 1-carbacefalosporina.
SE8405588D0 (sv) New compounds
IT1206130B (it) Composti per abbassare i livelli dei lipidi.
ES2020925B3 (es) Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.
BG47648A3 (bg) Метод за получаване на триазолилхинолинови съединения
FI98519B (fi) Menetelmä substituoitujen indolien valmistamiseksi
ES548878A0 (es) Un procedimiento para la preparacion de una forma polimorfo i de una sal de monoetanolamina
NO841372L (no) Fremgangsmaate for fremstilling av dipyridamol-preparater med ph-uavhengig regulert frigjoering
SE8303399D0 (sv) Azo-bis-salicyl syra och salt derav, deras farmaceutiska beredning samt framstellning av syran
NO165177C (no) Fremgangsmaate for fremstilling av et basesalt av piroxicam
SE7906681L (sv) Ftalazonderivat
SE8101963L (sv) Monohydrerad isoftalsyrapikolylamid, forfarande for dess framstellning samt farmaceutisk anvendning derav
SE8503109L (sv) Cykliska forstadielekemedel till antiinflammatoriska oxikamer
FI841272A (fi) Nya penemfoereningar, farmaceutiska blandningar innehaollande dessa, foerfarande foer deras framstaellning.
ES8407021A1 (es) Un procedimiento para la preparacion de derivados de acido 5-oxo-2-pirrolidinpropanoico.
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico